ArticleThe Lancet regional health. Europe2026
Microplastics in human lung tissue from autopsy samples collected in 1991 and 2024: a comparative post-mortem study.
Article in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
36 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Environmental accumulation and human exposure to microplastics MPs are increasing. It is not known whether there is a higher bioaccumulation of microplastics (MPs) in human lungs collected recently and compared with those collected decades ago. We aimed to assess changes in the presence, abundance, size, and types of MPs in human lung tissue collected 33 years apart, and to characterize histological patterns in these samples. Methods: We performed a comparative study of paraffin-embedded lung tissues collected post-mortem from two series of autopsy cases deceased either in 1991 (n = 42) or in 2024 (n = 57), both from the same tertiary care medical center. We assessed MPs prevalence, abundance, size, and polymer type using laser-direct infrared (LDIR) imaging. Particle count per gram of tissue was the primary endpoint. As supporting analysis, we evaluated MPs type and concentrations through pyrolysis-gas chromatography/mass spectrometry (Py-GC/MS) in a representative subset of samples. We also assessed collagen I staining to evaluate fibrosis and CD68 infiltration as an index of lung inflammation. Findings: MPs were identified by LDIR in lung samples from 8/42 individuals (19%) deceased in 1991 and 44/57 (77%) deceased in 2024. MP burden per gram of tissue (median; Q1-Q3) increased from 12.9 particles (11.3-13.7) to 19.9 (15.5-28.2), with results corroborated by a two-part hurdle model analysis. Particle diameter decreased from 56.2 μm (44.9-73.4) to 22.4 μm (15.4-37.9). When considering the mean ± SD of the relative abundance (%) of each plastic type/total MPs for each individual positive to MPs in the two groups, polymer composition shifted from polyethylene predominance (51.7 ± 2%) in 1991 to a more heterogeneous mix including polyethylene terephthalate (28.4 ± 3.1%), polyvinyl chloride (14.3 ± 2.4%), and polystyrene (14.2 ± 2.6%) in 2024. Py-GC/MS provided similar results in terms of MPs prevalence and relative abundance, while SEM suggested a pervasive presence of particles enriched in Sulphur in the 2024 group. Lung samples with evidence of MPs showed higher CD68 and collagen I abundance compared with those without evidence of MPs, independently of the case series. Interpretation: MPs contamination of human lung tissue was more frequently detected, showed greater polymer diversity, and was composed of smaller particles in post-mortem samples collected in 2024 compared with those collected in 1991. These observations are hypothesis-generating and should be interpreted in the context of the observational, cross-sectional, and retrospective nature of the study design. Funding: This work has been supported by Italian Ministry of Health through Ricerca Corrente to IRCCS MultiMedica, and by Ricerca Ateneofund for Outcomes Research in Cardiovascular Diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.